Guidance Provided for Transition From Pediatric to Adult Endocrine Care

Follow Drugslib on

By Elana Gotkine HealthDay Reporter

Medically reviewed by Carmen Pope, BPharm. Last updated on March 2, 2026.

via HealthDay

MONDAY, March 2, 2026 -- In a joint guidance document issued by the European Society for Paediatric Endocrinology and European Society of Endocrinology and published online Feb. 25 in the European Journal of Endocrinology, recommendations are presented for supporting structured and effective transition of young people with endocrine conditions from pediatric to adult health services.

Enora Le Roux, Ph.D., from Hôpital Universitaire Robert Debré in Paris, and colleagues developed European consensus guidance for the transition from pediatric to adult care in endocrine conditions using an evidence-based approach. A systematic literature review was conducted of 351 recommendations from 55 articles. A core multidisciplinary group developed guidance, which was refined through focus groups with 18 experts from 10 countries.

Recommendations were included across 11 domains: structure of transition service, patient empowerment, patient-professional relationship, multidisciplinary team organization, health care provider education, timing and planning, care coordination, management of nonattendance, psychological support, role of parents/caregivers, and readiness tools. Key features included core steps to support assessment of transition readiness, joint clinics, and formal transfer planning between pediatric and adult teams. To design personalized transition plans, practical recommendations are provided for endocrinologists, nurses, psychologists, and health professionals. To empower autonomy and adherence, guidance is provided for involving young people and their families in care decisions, goal setting, and self-management. To minimize care fragmentation during transfer, suggested tools and checklists capture medical history, risk factors, and ongoing needs.

"The Guidance emphasizes early planning, shared decision-making, coordinated clinical handovers, and education tailored to patients and families," Le Roux said in a statement.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2026-03-03 01:40

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords